Effects of a Genistein Combined Polysaccharide (GCP) on Patients With a Diagnosis of Prostate Cancer on Active Surveillance.
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Treatment
Reduction in PSA serum levels.
Robert Hackman, PhD
University of California, Davis
Japan: Ministry of Health, Labor and Welfare
|University of California, Davis||Sacramento, California 95818|